said has received permission resume marketing its diapulse pulsed high peak power electromagnetic energy medical device for treatment postoperative edema and pain superficial soft tissues company said had been enjoined from marketing product since 1972 due labeling impasse with food and drug administration said district court for eastern district new york modified injunction against sale product following motion filed jointly company and fda reuter 